Effect of Inflated Versus Non-inflated Endotracheal Tube on Sore Throat

January 25, 2024 updated by: Nitin Sethi, DNB, Sir Ganga Ram Hospital

Effect of Kinetic Contact-friction Modulation With a Pre-inflated Tracheal Tube Cuff on Postoperative Sore Throat in Adults With Anticipated Non-difficult Airway: a Randomized Controlled Study

Postoperative sore throat (POST) is a common morbidity following upper airway access-control with direct laryngoscopy-intubation (DLI) technique. Various reasons (size of the tracheal tube, cuff pressure, rough tube pass, and reattempts, among others) have been cited and management strategies (pharmacologic: applying lidocaine gel/EMLA cream on the cuff surface; non-pharmacologic measures: tracheal tube cuff pressure control, optimization of tracheal tube size, applying lubricating gel) have been tried, but none has been able to decrease the incidence of POST nor has been able to decrease the suffering of patients.

Traditionally, intubation is performed with a deflated endotracheal tube and the cuff is later inflated to secure the tube in desired position. The striated folds present in the deflated cuff incurs additional dynamic friction that traumatizes upper airway mucosa during the procedure, causing the risk of POST. While accentuated friction burden on the posterior part of vocal cords and the tracheal mucosa has been studied recently, there has been no work on understanding the kinetic contact- friction ensued by a passing tracheal tube/cuff. We speculate that dynamic contact-friction generated at the time of passing of a cuffed tracheal tube is the major active component which has potential to cause actual tissue trauma and inflammation resulting in adverse effects (POST, hoarseness, throat pain, cough). This study aims to evaluate the effects of reducing dynamic/kinetic contact-friction by employing a pre-inflated tracheal tube cuff to pass the vocal cords at the time of orotracheal intubation.

Study Overview

Detailed Description

Postoperative sore throat (POST) has long been a common and nagging complication following conventional direct laryngoscopy-intubation (DLI) procedure. A significant quantum of POST incidence during DLI in non-difficult airway (NDA) could be attributed to inter-operator variability in approach, experience, proficiency, and equipment (e.g., type of laryngoscope/tracheal tube). Additional factors determining the occurrence of POST, include size of the tracheal tube, cuff pressure, rough tube pass, and reattempts, among others. Several pharmacologic (applying lidocaine gel, inhaled corticosteroids and EMLA cream on tracheal tube cuff surface) and non- pharmacologic measures/modalities (e.g., tracheal tube cuff pressure control, optimization of tracheal tube size, applying gel) have been employed to preclude/diminish POST, however, neither the incidence nor the suffering of patients have come down yet following these interventions. Friction injury to the tracheal mucosa during the passage of ETT is one of the important contributing factors to POST but has not been adequately evaluated. Friction injury to the upper airway mucosa not only occurs during rough or repeated passage of ETT through the glottic-inlet but also when the ETT cuff comes in contact with the tracheal mucosa during dynamic passage of ETT through the glottis.

Traditional approach to reduce reduce postoperative sore throat is by containing the intracuff pressure with use of non-inflated tube, and consequently, reducing static pressure burden on tracheal mucosa. No study has explored the impact of modulation of obligate kinetic contact-friction that occurs during passage of tube across the glottic-inlet. A preemptive limited inflation of tracheal tube cuff before actual intubation may modulate the kinetic-contact friction during the passage of the tracheal tube cuff past the vocal cords, and hence may help reduce postoperative sore throat in these patients. We plan this randomized trial to compare the effect/efficacy of intubation with pre-inflated tracheal tube on the incidence of postoperative sore throat in patients with anticipated non-difficult airway.

Study Type

Interventional

Enrollment (Estimated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Delhi
      • New Delhi, Delhi, India, 110060
        • Recruiting
        • Sir Ganga Ram Hospital
        • Sub-Investigator:
          • Nitin Sethi, DNB
        • Contact:
        • Sub-Investigator:
          • Shvet Mahajan, DA, DNB
        • Principal Investigator:
          • Amitabh Dutta, MD, PGDHR
        • Contact:
        • Sub-Investigator:
          • Nitisha E Benny, MBBS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ASA physical status I and II
  • Patients with anticipated non-difficult airway with the following characteristics:

    i. Normal head and neck movements ii. Adequate mouth opening iii. No retrognathia or prognathia iv. Normal dentition

  • Surgeries with anticipated duration of 40 minutes - 3 hours

Exclusion Criteria:

  • Obese patients (BMI > 33 kg/m2)
  • Requiring use of intubation aids such as bougie, stylet or video-laryngoscope
  • Recent history of steroid or non-steroidal anti-inflammatory drug use
  • Systemic illness with presenting complaints of sore/dry throat (diabetics with polydipsia, hypertensives on diuretics, moribund bed ridden patients)
  • History of airway related morbidity post operative sore throat [POST]
  • Patients with a history of chronic smoking (1 pack per day for 10 years) chewing tobacco, and tobacco-related products
  • Patients undergoing head and neck, intraoral/nasal surgery, or recent history of such surgery
  • Patients with a past surgical history of tracheostomy (post decannulation)
  • Surgery in prone position
  • Ongoing upper and lower respiratory tract inflammation/infection
  • Patients with anticipated postoperative mechanical ventilation
  • Refusal to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Intubation with pre-inflated ETT
Patient's trachea will be intubated using pre- inflated endotracheal tube (ETT)
The ETT (males: size 7.5 mm ID, females: size 6.5 mmID) will be taken out from the wrapper and submerged in 0.9% normal saline till the proximal margin of the cuff. Then, the cuff will be inflated to 40 cm of H2O to gain full stretch inflation.Thereafter the cuff will be deflated with the help of cuff inflator-deflator device to maintain intracuff pressure of 4 cm H2O The external cuff balloon will be obliterated with a soft clamp to ensure that at the time of passage of tube through the glottic-inlet, the tube cuff does not get deflated due to pressure equalization with the external balloon.
Active Comparator: Intubation with non-inflated ETT
Patient's trachea will be intubated using non-inflated ETT
The ETT (males: size 7.5 mm ID, females: size 6.5 mmID) will be taken out from the wrapper and submerged in 0.9% normal saline till the proximal margin of the cuff. Thereafter the endotracheal intubation will be done.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of postoperative sore throat
Time Frame: From time of extubation of trachea till 24-hours postoperatively
Sore throat will be assessed using a 4-point scale: '0' no sore throat to '3' severe sore throat.Any score >= 1 will be counted as a sore throat incidence
From time of extubation of trachea till 24-hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of postoperative sore throat
Time Frame: From time of extubation of trachea till 24-hours postoperatively
Sore throat will be assessed using a 4-point scale: '0' no sore throat, '1' Mild sore throat (complained of sore throat only on enquiry), '2' Moderate sore throat (complained of sore throat on his/her own), and '3' Severe sore throat (change of voice or hoarseness). Number of patients with no sore throat, mild sore throat, moderate sore throat, and severe sore throat will be noted
From time of extubation of trachea till 24-hours postoperatively
Incidence and severity of postoperative cough
Time Frame: From time of extubation of trachea till 24-hours postoperatively
Postoperative cough will be assessed using a 4-point scale: 0- no cough, 1- mild cough (cough which is less than a common cold), 2-moderate cough (cough which is similar to a common cold), and 3- severe cough (cough which is more than a common cold).
From time of extubation of trachea till 24-hours postoperatively
Incidence and severity of postoperative hoarseness of voice
Time Frame: From time of extubation of trachea till 24-hours postoperatively
Postoperative hoarseness of voice will be assessed using a 4-point scale: 0- no hoarseness (no change in speech appreciated even on enquiry), 1- mild hoarseness (minimal change in speech quality. Answered by patient on enquiry), 2-moderate hoarseness (moderate change in speech quality which is self-complained by the patient), and 3- severe hoarseness (recognizable change in speech quality).
From time of extubation of trachea till 24-hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Amitabh Dutta, MD, PGDHR, Sir Ganga Ram Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 23, 2024

Primary Completion (Estimated)

January 30, 2025

Study Completion (Estimated)

January 30, 2025

Study Registration Dates

First Submitted

January 12, 2024

First Submitted That Met QC Criteria

January 12, 2024

First Posted (Actual)

January 23, 2024

Study Record Updates

Last Update Posted (Actual)

January 26, 2024

Last Update Submitted That Met QC Criteria

January 25, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Sore Throat

Clinical Trials on Pre-inflated endotracheal tube

3
Subscribe